Hugo Matern

This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Metabolic Disorder Treatments. Top assignee: Ngm Biopharmaceuticals, Inc.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hugo Matern. Retrieved from https://idiyas.com/inventor/hugo-matern

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 81.0

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 114(Granted Patents)

Company Filing History:

21 out of 73

Ngm Biopharmaceuticals, Inc.

patents

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Polynucleotides

Antibodies

Binding Proteins

Metabolic Disorders

Glucagon Receptor

Beta Klotho

Therapeutics

GDF15 Mutein

Nonalcoholic Steatohepatitis

Blood Glucose Levels

Human Subjects

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378312 - Polynucleotides encoding human beta klotho antibodies or binding fragments thereof and methods of use thereof (2025-08-05),

2. 12180289 - Binding proteins and methods of use thereof (2024-12-31),

3. 12173060 - Compositions and methods of use for treating metabolic disorders (2024-12-24),

4. 11732049 - Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor (2023-08-22),

5. 11667708 - Anti-human beta klotho antibody or binding fragment thereof and methods of their use (2023-06-06),

6. 11596676 - Methods of treating nonalcoholic steatohepatitis comprising administering an anti-human beta klotho antibody or binding fragment thereof (2023-03-07),

7. 11530260 - Compositions and methods of use for treating metabolic disorders (2022-12-20),

8. 10995145 - Antibodies which bind human glucagon receptor (2021-05-04),

9. 10975154 - Binding proteins and methods of use thereof (2021-04-13),

10. 10800843 - Beta klotho-binding proteins (2020-10-13),

11. 10744191 - Beta klotho-binding proteins and methods of use thereof (2020-08-18),

12. 10610568 - Compositions and methods of use for treating metabolic disorders (2020-04-07),

13. 10562965 - Compositions and methods of use for treating metabolic disorders (2020-02-18),

14. 10323075 - Compositions and methods of use for treating metabolic disorders (2019-06-18),

15. 10174119 - Binding proteins and methods of use thereof (2019-01-08),

Title: The Innovative Journey of Hugo Matern

Introduction: Hugo Matern, a visionary inventor based in San Mateo, CA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Hugo Matern's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary medical device for non-invasive surgery, and a sustainable energy solution for urban environments.

Career Highlights: With over two decades of experience in the tech industry, Hugo Matern has a proven track record of turning innovative ideas into reality. He has worked for leading tech companies, where he spearheaded research and development projects that have shaped the future of various industries.

Collaborations: Throughout his career, Hugo Matern has collaborated with top engineers, scientists, and researchers from renowned universities and research institutions. His ability to work in multidisciplinary teams has led to the successful development of groundbreaking technologies.

Conclusion: Hugo Matern's passion for innovation, coupled with his technical expertise, has established him as a prominent figure in the world of inventions. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.